top of page

Vicore Pharma's CEO describes the rationale for using angiotensin II type 2 receptor agonists in IPF

Ahmed Mousa describes what excited him to join the company from the U.S. one year ago, the unmet need that still exists in this large market, and what the path ahead is for the company's lead asset.




Kommentarer


Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

NYSE_logo_large_no reg_378x197 (1).png

The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants

bottom of page